Concepedia

Charles Butts

CB

Statistics

Publications

75

Citations

10.8K

H-Index

38

Active since

1918

Affiliations

Princess Margaret Cancer Centre(Current)

University of Alberta

University Health Network

Ottawa Hospital

Juravinski Cancer Centre

Charles Butts is an author at Princess Margaret Cancer Centre specializing in oncology, medicine, and non-small cell lung cancer therapy.

Publications per year

1918–2024

75

Publications

75

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

Timothy Winton, Robert B. Livingston, David C. Johnson et al. · New England Journal of Medicine · 2005 · 1.8K citations · Full text

, , +16

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer

Hossein Borghaei, Scott Gettinger, Everett E. Vokes et al. · Journal of Clinical Oncology · 2021 · 661 citations · Full text

, , +14

Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity

Carla M. Prado, Vickie E. Baracos, Linda J. McCargar et al. · Clinical Cancer Research · 2007 · 613 citations

, , +17

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

Charles Butts, Mark A. Socinski, Paul Mitchell et al. · The Lancet Oncology · 2013 · 526 citations · Full text

, , +13

XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer

Jim Cassidy, Josep Tabernero, Chris Twelves et al. · Journal of Clinical Oncology · 2004 · 525 citations · Full text

, , +9

1–5 of 75